Project: A novel blood purification device for treatment of sepsis, based on magnetic nanoparticles

Acronym SEPurate (Reference Number: 12806)
Duration 01/04/2019 - 02/04/2021
Project Topic The consortium will develop an innovative blood purification device for the treatment of sepsis (or blood poisoning), based on magnetic separation of bacterial endotoxins using targeted magnetic nanoparticles. In this project three individual components (1. extracorporeal blood circuit device, 2. nanomagnet handling units, 3. functionalized nanomagnets) of the technology will be developed and integrated into a prototype product ready for clinical evaluation, planned 12 months after the project.
Network Eurostars 2
Call Eurostars Cut–off 10

Project partner

Number Name Role Country
1 Hemotune AG Partner Switzerland
2 Wyss Zurich Partner Switzerland
3 Seleon GmbH Partner Germany